| Radiation dose estimation using preclinical imaging with‐metaiodobenzylguanidine (MIBG) PET CL Lee, H Wahnishe, GA Sayre, HM Cho, HJ Kim, ... Medical physics 37 (9), 4861-4867, 2010 | 76 | 2010 |
| A high-affinity [18 F]-labeled phosphoramidate peptidomimetic PSMA-targeted inhibitor for PET imaging of prostate cancer T Ganguly, S Dannoon, MR Hopkins, S Murphy, H Cahaya, JE Blecha, ... Nuclear medicine and biology 42 (10), 780-787, 2015 | 67 | 2015 |
| In vitro receptor binding assays: general methods and considerations HM Bigott-Hennkens, S Dannoon, MR Lewis, SS Jurisson The quarterly journal of nuclear medicine and molecular imaging 52 (3), 245, 2008 | 63 | 2008 |
| Tumor Dosimetry Using [124I]m-iodobenzylguanidine MicroPET/CT for [131I]m-iodobenzylguanidine Treatment of Neuroblastoma in a Murine Xenograft Model Y Seo, WC Gustafson, SF Dannoon, EA Nekritz, CL Lee, ST Murphy, ... Molecular imaging and biology 14, 735-742, 2012 | 44 | 2012 |
| Structure–Activity Relationship of 18F-Labeled Phosphoramidate Peptidomimetic Prostate-Specific Membrane Antigen (PSMA)-Targeted Inhibitor Analogues for … S Dannoon, T Ganguly, H Cahaya, JJ Geruntho, MS Galliher, SK Beyer, ... Journal of medicinal chemistry 59 (12), 5684-5694, 2016 | 36 | 2016 |
| Re (v) and Re (iii) complexes with sal 2 phen and triphenylphosphine: rearrangement, oxidation and reduction SR Lane, N Sisay, B Carney, S Dannoon, S Williams, HP Engelbrecht, ... Dalton transactions 40 (1), 269-276, 2011 | 22 | 2011 |
| The efficacy of the available peptide receptor radionuclide therapy for neuroendocrine tumors: a meta-analysis SF Dannoon, SA Alenezi, AH Elgazzar Nuclear medicine communications 38 (12), 1085-1093, 2017 | 19 | 2017 |
| Labeling, stability and biodistribution studies of 99mTc-cyclized Tyr3-octreotate derivatives HM Bigott-Hennkens, SF Dannoon, SM Noll, VC Ruthengael, SS Jurisson, ... Nuclear medicine and biology 38 (4), 549-555, 2011 | 19 | 2011 |
| Ultrastructure of hyperfunctioning parathyroid glands: does it explain various patterns of 99mTc-sestamibi uptake A Elgazzar, J Anim, S Dannoon, M Farghaly World Journal of Nuclear Medicine 16 (02), 145-149, 2017 | 15 | 2017 |
| In vitro structure–activity relationship of Re-cyclized octreotide analogues SF Dannoon, HM Bigott-Hennkens, L Ma, F Gallazzi, MR Lewis, ... Nuclear medicine and biology 37 (5), 527-537, 2010 | 15 | 2010 |
| The added value of SPECT-CT in the detection of heterotopic ossification on bone scintigraphy MA Ghanem, S Dannoon, AH Elgazzar Skeletal Radiology 49, 291-298, 2020 | 14 | 2020 |
| Scintigraphic patterns of indium-111 oxine-labeled white blood cell imaging of gram-negative versus gram-positive vertebral osteomyelitis AH Elgazzar, S Dannoon, I Sarikaya, M Farghali, TA Junaid Medical Principles and Practice 26 (5), 415-420, 2017 | 14 | 2017 |
| Synthesis and evaluation of constrained phosphoramidate inhibitors of prostate-specific membrane antigen CR Ley, NR Beattie, S Dannoon, M Regan, H VanBrocklin, CE Berkman Bioorganic & medicinal chemistry letters 25 (12), 2536-2539, 2015 | 12 | 2015 |
| Biodistribution and imaging studies of somatostatin receptors using technetium-99m-cyclized tyrosine-3-octreotate HM Bigott, SF Dannoon, SD Figueroa, TJ Hoffman, SS Jurisson, ... Technetium, Rhenium and Other Metals in Chemistry and Nuclear Medicine …, 2006 | 5 | 2006 |
| Structure-activity relationship of octreotide analogues labeled with rhenium and technetium-99m S Dannoon University of Missouri--Columbia, 2009 | 4 | 2009 |
| Radiosynthesis, rodent and non-human primate studies of a novel PET tracer for the excitatory amino acid transporter 2 (EAAT2) in the CNS J Gerdes, S Ahmed, M Braden, S Dannoon, J Blecha, H VanBrocklin Journal of Nuclear Medicine 56 (supplement 3), 1100-1100, 2015 | 2 | 2015 |
| Quantification of changes in skeletal muscle amino acid kinetics in adult humans in response to exercise via positron-emission tomography with L-[methyl-11C] methionine R Harnish, T Streeper, S Dannoon Journal of Molecular Imaging & Dynamics, 2012 | 2 | 2012 |
| TO BE OR NOT TO BE-Tb OR Lu?-BIOLOGICAL EVALUATION OF Tb-161-DOTA-TYR3-OCTREOTATE CS Cutler, M Cantorias, JC Kelsey, HP Engelbrecht, LJ Forbis, ... JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS 52, S96-S96, 2009 | 2 | 2009 |
| The efficacy of the available peptide receptor radionuclide therapy for neuroendocrine tumors SF Dannoon, SA Alenezi, AH Elgazzar a meta-analysis 2017, 38, 0 | 2 | |
| Effect of causative micro-organisms on patterns of labeled white blood cells in osteomyelitis SF Dannoon, W Al-Fouzan, SA Alenezi, M Alhusain, AH Elgazzar Indian Journal of Nuclear Medicine 34 (1), 27-31, 2019 | 1 | 2019 |
